| Tue, Oct 06, 2009 |
|
(BLUD) Immucor Beats Estimates – Reaffirmed Fiscal 2010 Revenue and Earnings Guidance
Recently, Immucor (BLUD) announced its first quarter (ending August 2009) 2010 earnings of 30 cents, which was better than the Zacks Consensus Estimate of 25 cents and the year ago quarter’s earnings of 28 cents. Net income in the quarter was $21.3 million, compared with $20.0 million for the same quarter last year.
The company reported [...]
(BLUD) Immucor Beats Estimates – Reaffirmed Fiscal 2010 Revenue and Earnings Guidance
|
| Sun, Sep 27, 2009 |
|
|
The week in preview: Is the rally over?
BloggingStocks: Autumn has arrived and the quarter winds down this week. The Dow has been inching toward 10,000 for a while now, though it closed lower in the past three sessions. Can it make it to 10,000 for the start of the third quarter? If so, what will push it ... Read more
-
BloggingStocks
|
| Sat, Sep 26, 2009 |
|
|
Earnings Preview For Sep 28 - Oct 2 - Earnings Preview
Five S&P 500 companies are confirmed to report: Constellation Brands (STZ), Darden Restaurants (DRI), Jabil Circuit (JBL), Nike (NKE) and Walgreen (WAG). A total of 27 companies are on the calendar. [More...] |
| Fri, Jul 24, 2009 |
|
|
Immucor Posts Record Revenues in FY09
Immucor (BLUD) reported net income of $19.4 million, or $0.27 per diluted share, for the fourth quarter of FY 2009, compared to $18.3 million, or $0.26 per diluted share, a year ago. Revenues grew 15.2% to $79.0 million on higher price and volume. Revenues include a negative forex impact of around $3 million y-o-y.? Gross margin contracted to 69.9% from 72.0%, mainly due to $1.8 million of expense incurred on the Quality Process Improvement Project. Operating expenses grew 22.9% to $26.1 million, primarily resulting from the takeover of BioArray and direct marketing initiatives in the France and United Kingdom. R&D grew 117.9% to $3.1 million (4.0% of revenues) and SGA grew 11.1% to $21.9 million (27.6% of revenues).? Reagents revenues grew 14.8% to $69.2 million – Traditional Reagents contributed $52.1 million [More...] |
| Mon, Jun 29, 2009 |
|
|
Looking For Solid, Growing Companies In A Recession
In dedication to my recent posts on value investing vs. trading strategies, I decided to focus this week’s screen to the market’s favorite word: growth. Specifically, the criteria used was positive revenue growth for the next fiscal year. Of course, this does not translate to earnings growth but management teams should have figured out there’s (...) [More...] |
|
More Blogs
|
